Biological Therapeutics, Inc.

Basic Information

3505 Riverview Circle
Moorhead, MN, 56560

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. THE LONG-TERM OBJECTIVE IS TO PREPARE AN EFFECTIVE LIPOSOME ENCAPSULATED REAGENT WHICH WILL BE PREFERENTIALLY TARGETED TO LIVER MACROPHAGES RESULTING IN MACROPHAGE ACTIVATION FOR THE THERAPY OF METASTATIC HEPATIC DISEASE.

    Amount: $50,000.00

    THE LONG-TERM OBJECTIVE IS TO PREPARE AN EFFECTIVE LIPOSOME ENCAPSULATED REAGENT WHICH WILL BE PREFERENTIALLY TARGETED TO LIVER MACROPHAGES RESULTING IN MACROPHAGE ACTIVATION FOR THE THERAPY OF METAST ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. THE LONG-TERM OBJECTIVE OF THE PROPOSAL IS TO CREATE AND EVALUATE THE EFFECTIVENESS OF MONOCLONAL ANTIBODY DIRECTED AGAINST THE RECEPTOR ON MALIGNANT CELLS RECOGNIZED BY ACTIVATED MACROPHAGES.

    Amount: $50,000.00

    THE LONG-TERM OBJECTIVE OF THE PROPOSAL IS TO CREATE AND EVALUATE THE EFFECTIVENESS OF MONOCLONAL ANTIBODY DIRECTED AGAINST THE RECEPTOR ON MALIGNANT CELLS RECOGNIZED BY ACTIVATED MACROPHAGES. MACROPH ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government